Ryan Irvine joined Hugel in November 2021 as Vice President, Medical Affairs.
He is an accomplished scientist and corporate executive working across technical fields for more than 15 years. In biotechnology, Dr. Irvine has accumulated direct and meaningful experience in medical communications, nonclinical and clinical development, regulatory strategy, commercialization, and product launch. He has held leadership roles in innovative companies focused on dermatology and aesthetics including Allergan, Kythera, and UNITY Biotechnology.
Dr. Irvine holds B.S. (Biochemistry) and M.S. (Neurobiology) degrees from Boston College and received his Ph.D. in Molecular Microbiology and Immunology from the University of Southern California.